Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.78 +0.15 (+0.52%)
Official Closing Price Updated: 7:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
3 Stocks That Are Down Big, But Are Due to Fall Much Further
While the search for falling stocks is an easy one, these are the ones that might not get up from the mat. 
Via InvestorPlace
PFE Stock Warning: Avoid This Big Pharma Value Trap at All Costs
PFE stock may look like a bargain among healthcare stocks, but despite its low valuation and high yield, further declines are likely. 
Via InvestorPlace
Why the dividend investor may take a look at NYSE:PFE.
Exploring PFIZER INC (NYSE:PFE)'s dividend characteristics. 
Via Chartmill
Looking At Pfizer's Recent Unusual Options Activity
Via Benzinga
10 Best Defensive Stocks To Invest In 2023
A defensive stock is a stock that demonstrates relatively stable performance regardless of the current state of the economy. Defensive stocks are less prone to the economic cycle of expansions and... 
Via Talk Markets
Topics Economy
Exposures Economy
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?
Vaccine revenue may have slipped but could still represent billions of dollars for these companies. 
Via The Motley Fool
Exposures COVID-19
Big Pharma’s Billion-Dollar Bets on Advanced Cancer Therapies
--News Direct-- 
Via News Direct
Exposures COVID-19
Analyzing NYSE:PFE's Dividend Potential.
Why PFIZER INC (NYSE:PFE) qualifies as a good dividend investing stock. 
Via Chartmill
Why NYSE:PFE is a Top Pick for Dividend Investors.
Why PFIZER INC (NYSE:PFE) is a Top Pick for Dividend Investors. 
Via Chartmill
Big Pharma Could Transform Into BioTech Pharma
As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Dividend Alert: Buy Pfizer Stock Before This Date!
Pfizer's growth story isn't only about the demand for Covid-19 vaccines, so value seekers ought to take a look at PFE stock while it's cheap. 
Via InvestorPlace
Exposures COVID-19
Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand
Last week, Novavax Inc (NASDAQ: NVAX) received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in  
Via Benzinga
Exposures COVID-19 Product Safety
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.  
Via Benzinga
Exposures COVID-19
Why NYSE:PFE qualifies as a good dividend investing stock.
Analyzing PFIZER INC (NYSE:PFE)'s Dividend Potential. 
Via Chartmill
Why NYSE:PFE provides a good dividend, while having solid fundamentals.
Why the dividend investor may take a look at PFIZER INC (NYSE:PFE). 
Via Chartmill
Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market
Contract drug manufacturers are investing billions of dollars in expanding or constructing facilities that fill the injection pens used for weight-loss drugs like Novo Nordisk A/S's (NYSE: NVO)... 
Via Benzinga
7 Dividend Stocks Ready to Roar Into 2024
Explore these robust dividend stocks to buy, ensuring a continuous income stream and fortifying your investment journey amid market flux. 
Via InvestorPlace
7 F-Rated Stocks to Kick to the Curb in October
Why would you subject your portfolio – and your financial future to F-rated stocks that are likely to drag your earnings down? 
Via InvestorPlace
3 Pharma Stocks to Dump Before the Damage Is Done
There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears. 
Via InvestorPlace
2 Growth Stocks That Could Rocket Higher Before the End of 2023
Potential approvals of new medicines expected soon could push these stocks through the roof. 
Via The Motley Fool
3 Biotech Stocks Ready to Break Out in 2024
These top three biotech companies are ready to roar into the new year with promising new trials, drugs, and innovative use of AI. 
Via InvestorPlace
This Could be Novavax's Big Opportunity
Novavax has lagged behind bigger rivals in the vaccine market. 
Via The Motley Fool
Better Growth Stock: Novo Nordisk vs. Pfizer
Which of these two pharmaceutical giants should you add to your portfolio? 
Via The Motley Fool
GSK Cuts Stake In Consumer Healthcare Business Haleon, Raises Around $1B
GSK Plc (NYSE: GSK) said it raised £885.6 million ( 
Via Benzinga
Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market?
Moderna, Pfizer, and Novavax all are working on combined vaccine candidates. 
Via The Motley Fool
Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute
Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infrin 
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures COVID-19 Financial Intellectual Property
No Merck's COVID-19 Pill - US Government Ceases Free Distribution
The U.S. government is set to cease the distribution of free doses of Merck & Co Inc's (NYSE: MRK) COVID-19 antiviral treatment Lagevrio (molnupiravir), by mid-November, shifting its availability to... 
Via Benzinga
Exposures COVID-19
Why Novavax Stock Fell Today
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated... 
Via Benzinga
Exposures COVID-19 Product Safety
Mainz Biomed Continues To Transform Early Cancer Detection Across The Globe
While Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) are making great progress in cancer treatments, the importance of early detection in combating this disease cannot be overstated. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.